The present invention relates to a novel sortase A (SrtA) inhibitory compound N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-2-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetamide which can be used in medicine as anti-infective agent for treating gram-positive bacterial infection.